Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg

(Reuters) - Pfizer Inc is exploring sale of a group of treatments in cardiology, urology and primary care, Bloomberg reported on Thursday, citing people familiar with the matter. The drugs could fetch more than $2 billion (£1.6 billion), Bloomberg reported. Pfizer is working with financial adviser JPMorgan Chase & Co for the potential portfolio sale and the process is at a preliminary stage, Bloomberg said. Pfizer could not be immediately reached for comment. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio D'Souza)